Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/79544
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | Effects of Streptococcus thermophilus TH-4 in a rat model of doxorrubicin-induced mucositis |
Author: | Wang, H. Brook, C. Whittaker, A. Lawrence, A. Yazbek, R. Howarth, G. |
Citation: | Scandinavian Journal of Gastroenterology, 2013; 48(8):959-968 |
Publisher: | Taylor & Francis As |
Issue Date: | 2013 |
ISSN: | 0036-5521 1502-7708 |
Statement of Responsibility: | Hanru Wang, Caitlin L. Brook, Alexandra L. Whittaker, Andrew Lawrence, Roger Yazbeck and Gordon S. Howarth |
Abstract: | BACKGROUND: Mucositis is a debilitating intestinal side effect of chemotherapeutic regimens. Probiotics have been considered a possible preventative treatment for mucositis. Streptococcus thermophilus TH-4 (TH-4), a newly identified probiotic, has been shown to partially alleviate mucositis induced by administration of the antimetabolite chemotherapy drug, methotrexate in rats; likely mediated through a mechanism of folate production. However, its effects against other classes of chemotherapy drug have yet to be determined. Aims. The authors investigated the effects of TH-4 in a rat model of mucositis induced by the anthracycline chemotherapy drug, doxorubicin. METHODS: Gastrointestinal damage was induced in female Dark Agouti rats (148.3 ± 1.5 g) by intraperitoneal injection of doxorubicin (20 mg/kg). Animals recieved a daily oral gavage of TH-4 at 109 cfu/ml or skim milk (vehicle) from days 0 to 8. At day 6, rats were injected with either saline or doxorubicin. At kill, small intestinal tissues were collected for determination of sucrase and myeloperoxidase (MPO) activities and histological assessment. RESULTS: Body weight was significantly decreased by doxorubicin compared with normal controls (p < 0.05). Histological parameters, such as crypt depth and villus height, were also significantly decreased by doxorubicin. TH-4 partially prevented the loss of body weight induced by doxorubicin (2.3% compared with 4%), but provided no further therapeutic benefit. CONCLUSIONS: The minimal amelioration of doxorubicin-induced mucositis by TH-4 further supports folate production as a likely mechanism of TH-4 action against methotrexate-induced mucositis. Further studies into TH-4 are required to confirm its applicability to other conventional chemotherapy regimens. |
Keywords: | Cancer chemotherapy doxorubicin mucositis probiotics Streptococcus thermophilus |
Rights: | © 2013 Informa Healthcare |
DOI: | 10.3109/00365521.2013.812142 |
Published version: | http://dx.doi.org/10.3109/00365521.2013.812142 |
Appears in Collections: | Animal and Veterinary Sciences publications Aurora harvest 4 |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.